The gene structure of human anti-haemophilic factor IX - PubMed (original) (raw)

The gene structure of human anti-haemophilic factor IX

D S Anson et al. EMBO J. 1984 May.

Abstract

The mRNA sequence of the human intrinsic clotting factor IX (Christmas factor) has been completed and is 2802 residues long, including a 29 residue long 5' non-coding and a 1390 residue long 3' non-coding region, but excluding the poly(A) tail. The factor IX gene is approximately 34 kb long and we define, by the sequencing of 5280 residues, the presumed promoter region, all eight exons, and some intron and flanking sequence. Introns account for 92% of the gene length and the longest is estimated to be 10 100 residues. Exons conform roughly to previously designated protein regions, but the catalytic region of the protein is coded by two separate exons. This differs from the arrangement in the other characterized serine protease genes which are further subdivided in this region.

PubMed Disclaimer

Similar articles

• DNA sequence analysis of three inhibitor-positive hemophilia B patients without gross gene deletion: identification of four novel mutations in factor IX gene.
  Matsushita T, Tanimoto M, Yamamoto K, Sugiura I, Hamaguchi M, Takamatsu J, Kamiya T, Saito H. Matsushita T, et al. J Lab Clin Med. 1990 Oct;116(4):492-7. J Lab Clin Med. 1990. PMID: 2212858
• The molecular genetics of hemophilia: blood clotting factors VIII and IX.
  Lawn RM. Lawn RM. Cell. 1985 Sep;42(2):405-6. doi: 10.1016/0092-8674(85)90094-7. Cell. 1985. PMID: 2992799 Review. No abstract available.
• Expression of active human blood clotting factor IX in transgenic mice: use of a cDNA with complete mRNA sequence.
  Choo KH, Raphael K, McAdam W, Peterson MG. Choo KH, et al. Nucleic Acids Res. 1987 Feb 11;15(3):871-84. doi: 10.1093/nar/15.3.871. Nucleic Acids Res. 1987. PMID: 3029708 Free PMC article.
• Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX.
  Jaye M, de la Salle H, Schamber F, Balland A, Kohli V, Findeli A, Tolstoshev P, Lecocq JP. Jaye M, et al. Nucleic Acids Res. 1983 Apr 25;11(8):2325-35. doi: 10.1093/nar/11.8.2325. Nucleic Acids Res. 1983. PMID: 6687940 Free PMC article.
• Structure and function of factor IX: defects in haemophilia B.
  McGraw RA, Davis LM, Lundblad RL, Stafford DW, Roberts HR. McGraw RA, et al. Clin Haematol. 1985 Jun;14(2):359-83. Clin Haematol. 1985. PMID: 3899439 Review.

Cited by

• A Machine Learning Framework Predicts the Clinical Severity of Hemophilia B Caused by Point-Mutations.
  Lopes TJS, Nogueira T, Rios R. Lopes TJS, et al. Front Bioinform. 2022 Jun 23;2:912112. doi: 10.3389/fbinf.2022.912112. eCollection 2022. Front Bioinform. 2022. PMID: 36304295 Free PMC article.
• Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product.
  Zacchi LF, Roche-Recinos D, Pegg CL, Phung TK, Napoli M, Aitken C, Sandford V, Mahler SM, Lee YY, Schulz BL, Howard CB. Zacchi LF, et al. Commun Biol. 2021 Mar 23;4(1):390. doi: 10.1038/s42003-021-01903-x. Commun Biol. 2021. PMID: 33758337 Free PMC article.
• World Federation of Hemophilia Gene Therapy Registry.
  Konkle BA, Coffin D, Pierce GF, Clark C, George L, Iorio A, Mahlangu J, Naccache M, O'Mahony B, Peyvandi F, Pipe S, Quartel A, Sawyer EK, Skinner MW, Tortella B, Watson C, Winburn I; Members of the WFH Gene Therapy Registery Steering Committee. Konkle BA, et al. Haemophilia. 2020 Jul;26(4):563-564. doi: 10.1111/hae.14015. Epub 2020 May 27. Haemophilia. 2020. PMID: 32462720 Free PMC article. No abstract available.
• Gene therapy for haemophilia.
  Sharma A, Easow Mathew M, Sriganesh V, Reiss UM. Sharma A, et al. Cochrane Database Syst Rev. 2020 Apr 28;4(4):CD010822. doi: 10.1002/14651858.CD010822.pub4. Cochrane Database Syst Rev. 2020. PMID: 32342499 Free PMC article.
• Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B.
  Krooss S, Werwitzke S, Kopp J, Rovai A, Varnholt D, Wachs AS, Goyenvalle A, Aarstma-Rus A, Ott M, Tiede A, Langemeier J, Bohne J. Krooss S, et al. PLoS Genet. 2020 Apr 8;16(4):e1008690. doi: 10.1371/journal.pgen.1008690. eCollection 2020 Apr. PLoS Genet. 2020. PMID: 32267853 Free PMC article.

References

1. 1. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3961-5 - PubMed
2. 1. Nature. 1976 Sep 16;263(5574):211-4 - PubMed
3. 1. Science. 1977 Apr 8;196(4286):180-2 - PubMed
4. 1. Cell. 1977 Nov;12(3):721-32 - PubMed
5. 1. Cell. 1977 Dec;12(4):1085-95 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource